Related Practice Life Sciences & Pharma Notwithstanding COVID-19, existing infectious diseases wreak significant health, social and economic havoc across the world each year. 01262021170148
Case Study Life Sciences & Pharma Cost and Reimbursement Assessment for a Biopharmaceutical Company May 7, 2024 A large biopharmaceutical company developing chimeric antigen receptor T-cell (CAR-T) therapies
Article Mental and Behavioral Health Exploring the Psychedelics Landscape: Looking Ahead to Funding in 2024 February 20, 2024
Executive Insights Business Services Benefits of the 4-Day Week: The Jury Is Still Out October 31, 2023
Executive Insights Life Sciences & Pharma Initial Drugs Selected for Medicare Price Negotiation: Emerging Perspectives September 1, 2023
Executive Insights Life Sciences & Pharma Navigating the Shifting Landscape in Life Sciences: Trends and Implications July 31, 2023